News coverage about Markel (NYSE:MKL) has been trending somewhat positive on Thursday, Accern reports. Accern identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Markel earned a news sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the insurance provider an impact score of 46.0062885518452 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Several research firms have issued reports on MKL. SunTrust Banks restated a “hold” rating and issued a $1,100.00 price target on shares of Markel in a research report on Friday, October 27th. Zacks Investment Research lowered shares of Markel from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Royal Bank of Canada reaffirmed a “hold” rating and issued a $1,050.00 price objective on shares of Markel in a research note on Tuesday, October 3rd. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Markel in a research note on Thursday, October 26th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $1,066.67.

Shares of Markel (NYSE:MKL) traded down $0.14 during trading hours on Thursday, hitting $1,120.40. 47,346 shares of the company’s stock were exchanged, compared to its average volume of 7,200. The firm has a market cap of $15,700.00, a price-to-earnings ratio of 367.77 and a beta of 1.05. Markel has a 52 week low of $612.00 and a 52 week high of $1,135.40. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.28.

In other Markel news, Vice Chairman Steven A. Markel sold 200 shares of Markel stock in a transaction on Thursday, September 28th. The shares were sold at an average price of $1,065.64, for a total transaction of $213,128.00. Following the completion of the sale, the insider now owns 109,550 shares of the company’s stock, valued at approximately $116,740,862. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Lemuel E. Lewis bought 1,000 shares of the firm’s stock in a transaction on Wednesday, November 8th. The shares were bought at an average cost of $1,080.96 per share, with a total value of $1,080,960.00. Following the purchase, the director now directly owns 5,294 shares in the company, valued at $5,722,602.24. The disclosure for this purchase can be found here. Insiders have sold a total of 2,307 shares of company stock valued at $2,510,338 in the last three months. Company insiders own 2.53% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Markel (MKL) Receiving Somewhat Favorable Media Coverage, Study Finds” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/12/14/markel-mkl-receiving-somewhat-favorable-media-coverage-study-finds.html.

About Markel

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.